SCHEDULE: Vanguard Group Reports 0% Globus Medical Stake

The Vanguard Group has reported a 0% beneficial ownership in Globus Medical Inc. common stock following an internal realignment.

Summary

• The Vanguard Group filed an Amendment No. 13 to Schedule 13G for Globus Medical Inc. common stock.
• The filing indicates that The Vanguard Group now holds 0% beneficial ownership of Globus Medical Inc. common stock.
• This change is attributed to an internal realignment within The Vanguard Group, effective January 12, 2026.
• Following the realignment, certain subsidiaries or business divisions of The Vanguard Group, Inc. will report beneficial ownership separately (on a disaggregated basis).
• The Vanguard Group, Inc. no longer has, or is deemed to have, beneficial ownership over securities beneficially owned by these subsidiaries and/or business divisions, in accordance with SEC Release No. 34-39538.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, primarily a procedural update regarding The Vanguard Group's internal reporting structure and beneficial ownership disclosure, with no direct positive or negative implications for Globus Medical Inc.'s operational or financial performance.

Future Outlook

NA

Management Comments

• On January 12, 2026, The Vanguard Group, Inc. went through an internal realignment.
• In accordance with SEC Release No. 34-39538 (January 12, 1998), certain subsidiaries or business divisions of subsidiaries of The Vanguard Group, Inc., that formerly had, or were deemed to have, beneficial ownership with The Vanguard Group, Inc., will report beneficial ownership separately (on a disaggregated basis) from The Vanguard Group, Inc. in reliance on such release.
• These subsidiaries and/or business divisions pursue the same investment strategies as previously pursued by The Vanguard Group, Inc. prior to the realignment.
• The Vanguard Group, Inc. no longer has, or is deemed to have, beneficial ownership over securities beneficially owned by such subsidiaries and/or business divisions.

Industry Context

StockSavvy.ai notes that institutional investors like The Vanguard Group frequently adjust their reporting structures and beneficial ownership disclosures. This particular filing reflects an internal organizational change at Vanguard rather than a strategic investment decision related to Globus Medical's performance or industry trends. It highlights the ongoing evolution of reporting requirements and internal operational adjustments within large asset management firms.

Stakeholder Impact

• Shareholders (Globus Medical): No direct impact on the company's operations or value, but it clarifies that Vanguard Group (the parent entity) no longer directly holds shares, though its subsidiaries may.
• The Vanguard Group (Parent Entity): Streamlines reporting by disaggregating beneficial ownership to subsidiaries/divisions.

Key Dates

Keywords

Globus Medical Inc, Vanguard Group, Schedule 13G, Beneficial Ownership, Common Stock, Institutional Investor, SEC Filing, Ownership Change, Investment Adviser